Sinadjan, Arcely N.
HRN: 24-21-03 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2023
CEFUROXIME 500MG (TAB)
12/13/2023
12/20/2023
PO
500mg
BID
2 Degree RMLE
Waiting Final Action